CRO

Our fully-experienced staffs provide good supports to pharmaceutical affairs regarding regenerative medicine products, including communication with PMDA and preparation of documents for it.

We also provide extensive supports to establish manufacturing process of regenerative medicines regarding to various level of facility controls and document preparations required in “ Act on Securing Safety of Regenerative Medicine (Act No. 85 of 2013)”